13F filing recap · Q2 2017
What did Viking Global Investors buy in Q2 2017?
Reported stock-position changes between this filing and the previous one.
Stock value
$14.85B
Positions
53
Estimated turnover
79.0%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
WFCWells Fargo & Company/mn$681.39Mreported value+12.30M sharesAPCAnadarko Petroleum Corporation$179.77Mreported value+3.96M sharesAFLAflac Inc$165.75Mreported value+2.13M sharesBABAAlibaba Group Holding Limited$155.12Mreported value+1.10M sharesTDGTransdigm Group Incorporated$143.54Mreported value+533.9K sharesMOHMolina Healthcare, Inc.$102.17Mreported value+1.48M sharesRJFRaymond James Financial Inc$76.72Mreported value+956.3K sharesFLTFleetcor Technologies, Inc.$68.45Mreported value+474.7K sharesNSCNorfolk Southern Corp$57.21Mreported value+470.1K sharesLOWLowe’s Companies, Inc.$57.07Mreported value+736.0K sharesMRSHMarsh & Mclennan Companies, Inc.$54.43Mreported value+698.1K sharesELVElevance Health, Inc.$53.93Mreported value+286.7K sharesZBHZimmer Biomet Holdings, Inc.$51.06Mreported value+397.7K sharesKITEKite Pharma Inc$49.78Mreported value+480.2K sharesEXPEExpedia Group, Inc.$47.66Mreported value+320.0K sharesNDRMNeuroderm Ltd.$21.20Mreported value+708.9K shares